Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading update

15 Jan 2021 07:00

RNS Number : 7819L
Babcock International Group PLC
15 January 2021
 

15 January 2021 

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the aerospace and defence company, issues the following trading update for the first nine months of the financial year ending 31 March 2021.

 

Group trading

Trading in the third quarter saw a continuation of trends in the first half of the year, with weakness in our civil aviation businesses and a negative impact from COVID-19.

 

Underlying revenue in the nine months year to date (YTD) was £3,399 million (9M 2020: £3,574 million), down 3% on last year excluding disposals and FX. Underlying operating profit in the nine months YTD was £202 million (9M 2020: £320 million), down 34% excluding disposals and FX, with a negative impact from civil nuclear insourcing, COVID-19 and civil aviation.

 

Order intake YTD was £3.1 billion with the Group's order book standing at £16.8 billion at 31 December 2020 (31 March 2020: £17.6 billion).

 

Balance sheet

The Group's net debt1 (excluding lease obligations) at 31 December 2020 was £1,207 million, a reduction of £255 million compared to 31 December 20192. Although this position is higher than that reported at 30 September 2020 of £871 million, it is consistent with the average net debt for the first nine months of this financial year of £1,222 million3.

 

Review of contract profitability and balance sheet

We have recently started a detailed review of our balance sheet and contract profitability. Early indications suggest that there may be negative impacts on the balance sheet and/or income statement for current and/or future years. This review is being supported by an independent accounting firm and the outputs will be reviewed by our auditor (PWC), Audit Committee and Board prior to the publication of our audited results for the year ending 31 March 2021 expected in May.

 

Outlook

Uncertainty remains around the outturn for this financial year, especially given that our fourth quarter is historically our strongest and that the COVID-19 situation has worsened in most of our markets. Given this uncertainty, and the start of our review of contract profitability and balance sheet, we continue not to provide financial guidance for this financial year.

 

Review of strategic priorities

We announced a review of the Group's strategic priorities in November 2020 and this is now well underway. Our focus throughout this review will be on cash delivery, being a strategic partner to the UK Government, international growth, driving innovation across the Group, and transforming our ESG and people agenda. We will outline our refreshed strategy alongside our full year results.

 

David Lockwood, CEO said:

"While trading in the third quarter has continued to reflect the challenges of the first half and there remain a number of near term uncertainties, the fundamental strengths of the Group and the opportunities ahead give us confidence for future years and I look forward to reporting back at the full year results".

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

 

FTI Consulting

John Waples / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Notes

1. Net debt includes the benefit of ongoing receivables factoring and supply chain finance programmes.

2. This includes net proceeds from the sales of Context, Holdfast and Conbras of £194 million.

3. Based on the average of nine month end positions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSEELEFSEFF
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.